Wendell Heard
Sports Medicine · New Orleans, LANPI 1679790554
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 62.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $11,751 and has fallen 93.9% since, to $713 in 2025.
Across 78 payments — averaging $211.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Vericel Corporation$4K
- Xiros Inc$790
- Stryker$622
- Miach Orthopaedics, Inc.$365
- ALON Medical Technology$136
- plus $555 from 14 others
What the payments were for
- Consulting fees$5,70035%
- Speaking & faculty fees$4,77329%
- Travel & lodging$1,71310%
- Food & beverage$4,32426%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 29 | $10,360 |
| Vericel Corporation | 11 | $3,680 |
| Xiros Inc | 5 | $790 |
| Stryker | 13 | $622 |
| Miach Orthopaedics, Inc. | 2 | $365 |
| ALON Medical Technology | 2 | $136 |
| Trice Medical, Inc. | 1 | $128 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Globus Medical | 1 | $48 |
| Ossio Inc | 1 | $47 |
| Bioventus LLC | 2 | $37 |
| Zimmer Biomet | 2 | $28 |
| Davol Inc. | 1 | $26 |
| Innovation Technologies Inc | 1 | $26 |
| Medacta USA, Inc. | 1 | $25 |
| Anika Therapeutics, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Vertex | 1 | $13 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Regeneten$5,167
- Q-FIX$4,773
- HEALICOIL REGENESORB$4,773
- LENS 4K$4,773
- MICRORAPTOR REGENESORB$4,773
- MACI$3,425
- Accu-pass$2,400
- NOVOSTITCH PRO$884
- BIORAPTOR$798
- NOVOSTITCH$798
- Hip Pac$798
- Meniscal Root Repair System$555
- GTS System$447
- Coblator II$447
- TRUNAV$447
- LENS$447
- REGENETEN Shoulder$437
- FAST-FIX FLEX$437
- HEALICOIL PK Hip$437
- Dyonics Mini Shaver System$395
How this compares
$16,509 in reported general payments places this provider in the 80th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $85 |
| Meloxicam | 15 | $21 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New Orleans
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brian GodshawNew Orleans$69K
- Paul PhillipsNew Orleans$26K
- Russell RussoNew Orleans$16K
- Kelly HillNew Orleans$9K
- Scott MontgomeryNew Orleans$7K
- Brett CascioLake Charles$82K
- Andrew GottschalkJefferson$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.